Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Clinical trial NCT04541108 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04541108
- Sponsor
- Presage Biosciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-26
- Primary completion
- 2031-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.